Indian Policyholders Face Soaring Premiums
Over 70% of Indian health policyholders have faced premium hikes of 50-200%. On top of that, 40% report their claims were either rejected or only partially approved for questionable reasons, highlighting widespread issues in the country's health insurance market.
A key driver behind the premium surge is India's medical inflation, which has been rising at an alarming 12-15% annually, outpacing general inflation and ranking among the highest in Asia. This is fueled by the rising costs of advanced medical technology, new treatments, and general hospital operational expenses, which insurers pass on to policyholders. According to the Insurance Regulatory and Development Authority of India (IRDAI), insurers rejected 11% of all health insurance claims in the 2023-24 fiscal year. In terms of value, claims amounting to ₹15,100 crore, or 12.9% of the total amount filed, were disallowed during the same period. Many rejections stem from policy-related clauses rather than the merit of the medical case itself. Common reasons include the non-disclosure of pre-existing conditions at the time of policy purchase, filing a claim within the mandatory waiting period for certain diseases, and submitting incomplete or incorrect paperwork. The claims process is often managed by Third-Party Administrators (TPAs), intermediaries licensed by IRDAI to handle documentation and hospital coordination. While TPAs process the majority of claims—around 72%—the final decision to approve or deny the claim rests solely with the insurance company. In response to the escalating costs, India's Department of Financial Services (DFS) has intervened, convincing major hospital chains to freeze their treatment charges for 2026. This move is aimed at stabilizing health insurance premiums for the upcoming year by directly controlling a major component of insurers' claim expenses. The insurance regulator, IRDAI, has also introduced new consumer protection measures. These include capping annual premium increases for senior citizens at 10% without prior approval and reducing the maximum waiting period for pre-existing conditions from four years to three.
